title: Cytotoxicity assessment of modified bioactive glasses with MLO-A5 osteogenic cells in vitro.
abstract: The primary objective of this study was to evaluate in vitro responses of MLO-A5 osteogenic cells to two modifications of the bioactive glass 13-93. The modified glasses, which were designed for use as cell support scaffolds and contained added boron to form the glasses 13-93 B1 and 13-93 B3, were made to accelerate formation of a bioactive hydroxyapatite surface layer and possibly enhance tissue growth. Quantitative MTT cytotoxicity tests revealed no inhibition of growth of MLO-A5 cells incubated with 13-93 glass extracts up to 10 mg/ml, moderate inhibition of growth with 13-93 B1 glass extracts, and noticeable inhibition of growth with 13-93 B3 glass extracts. A morphology-based biocompatibility test was also performed and yielded qualitative assessments of the relative biocompatibilities of glass extracts that agree with those obtained by the quantitative MTT test. However, as a proof of concept experiment, when MLO-A5 cells were seeded onto 13-93 B3 scaffolds in a dynamic in vitro environment, cell proliferation occurred as evidenced by qualitative and quantitative MTT labeling of scaffolds. Together these results demonstrate the in vitro toxicity of released borate ion in static experiments; however borate ion release can be mitigated in a dynamic environment similar to the human body where microvasculature is present. Here we argue that despite toxicity in static environments, boron-containing 13-93 compositions may warrant further study for use in tissue engineering applications.
authors: Department of Biological Sciences, Center for Bone and Tissue Repair and Regeneration, Missouri University of Science and Technology, Rolla, MO 65409, USA. vmodglin@mo-sci.com
authors: Vernon C
authors: VC
authors: Modglin
authors: Roger F
authors: RF
authors: Brown
authors: Steven B
authors: SB
authors: Jung
authors: Delbert E
authors: DE
authors: Day
mesh_terms: D000818:Animals; D001895:Boron / Q000737:chemistry* / Q000494:pharmacology; D001896:Boron Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D049109:Cell Proliferation / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D005562:Formazans / Q000494:pharmacology; D005898:Glass / Q000737:chemistry*; D051379:Mice; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D013778:Tetrazolium Salts / Q000494:pharmacology; D023822:Tissue Engineering / Q000295:instrumentation; D054457:Tissue Scaffolds / Q000009:adverse effects
chemical_list: C553965:13-93 bioactive glass; D001896:Boron Compounds; D005562:Formazans; D013778:Tetrazolium Salts; C079782:MTT formazan; D001895:Boron
references: J Biomed Mater Res A. 2007 Nov;83(2):530-7
references: 17508414
references: J Biomed Mater Res B Appl Biomater. 2006 Jul;78(1):97-104
references: 16292763
references: Methods Mol Med. 2005;110:69-78
references: 15901928
references: Biomaterials. 2001 Jan;22(2):175-85
references: 11101161
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Environ Health Perspect. 1994 Nov;102 Suppl 7:107-12
references: 7889869
references: J Bone Miner Res. 2001 Sep;16(9):1622-33
references: 11547831
references: Acta Biomater. 2008 Mar;4(2):387-96
references: 17768097
references: Science. 1984 Nov 9;226(4675):630-6
references: 6093253
references: Biomaterials. 2002 Jun;23(12):2599-606
references: 12033609
references: Biomaterials. 1994 Jan;15(2):97-106
references: 8011866
references: J Biomed Mater Res. 1997 Jul;36(1):109-17
references: 9212395
references: J Biomed Mater Res. 1997 Oct;37(1):114-21
references: 9335356
references: Acta Biomater. 2008 Nov;4(6):1854-64
references: 18519173
references: Biomaterials. 2000 Dec;21(23):2347-59
references: 11055282
references: Clin Orthop Relat Res. 1999 Oct;(367 Suppl):S419-23
references: 10546664
references: Biomed Mater. 2006 Sep;1(3):100-5
references: 18458389
references: Biomaterials. 2000 Dec;21(24):2529-43
references: 11071603
references: J Biomed Mater Res A. 2003 Feb 1;64(2):235-41
references: 12522809
references: J Biomed Mater Res B Appl Biomater. 2006 May;77(2):227-33
references: 16258958
references: J Biomed Mater Res. 1999 Mar 15;44(4):407-15
references: 10397944
references: Biomaterials. 2000 Dec;21(24):2495-505
references: 11071599
references: Biomaterials. 2006 Mar;27(7):964-73
references: 16102812
references: Biol Trace Elem Res. 2002 Jan;85(1):23-33
references: 11881796
references: J Biomed Mater Res A. 2009 Feb;88(2):392-400
references: 18306284
references: Calcif Tissue Int. 2006 Nov;79(5):340-53
references: 17115241